The Europe Sleep Apnea Devices Market would witness market growth of 6.8% CAGR during the forecast period (2019-2025).
The best way to treat obstructive sleep apnea (OSA) is via the CPAP machine. Oral appliance therapy is an alternative treatment. One appliance resembles a mouthguard. The tongue is stabilized by another dental device. Oral appliance therapy in patients diagnosed with obstructive sleep apnea is progressively being used as a non-invasive treatment option. The prescribed types of oral appliances are the custom-made titratable mandibular advancement devices (MAD). Mandibular advancement devices are effective in minimizing the frequency of obstructive sleep apnea, while using continuous positive airway pressure (CPAP) only to a lesser degree than regular therapy.
Actigraphy devices (actometer or actimeter) use a portable unit, typically worn on the wrist, which tracks physical activity over a longer period of time. This technology is progressively being used in clinical settings, because actigraphy has the benefit of providing accurate information about the sleep patterns in the regular sleep environment of patients.
Advancements in sleep apnea research contributed to the development of many common apnea treatments for sleep. Moreover, many companies are involved in the development of sophisticated equipment that increases demand for this equipment. Largely untapped opportunities in emerging countries can, over time, accelerate sector growth. Awareness and favorable reimbursement may increase acceptance among humans of devices related to sleep apnea disorders.
Based on Product Type, the market is segmented into Therapeutic Devices and Diagnostic Devices. Based on Therapeutic Devices Type, the market is segmented into PAP Devices, Oral Devices, Nasal Devices and Chin Straps. Based on Diagnostic Devices Type, the market is segmented into Polysomnography, Respiratory Polygraphs, Pulse Oximeters and Actigraphs. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., Fisher & Paykel Healthcare Corporation Limited, SomnoMed Limited, Mitsui Chemical, Inc. (Whole You, Inc.), Teleflex, Inc., ResMed, Inc., Oventus Medical Ltd., Panthera Dental, Inc. (Panthera Sleep), BRAEBON Medical Corporation, and BMC Medical Co., Ltd.
Scope of the Study
Market Segmentation:
By Product Type

  • Therapeutic Devices and
  • Diagnostic Devices


By Therapeutic Devices Type

  • PAP Devices
  • Oral Devices
  • Nasal Devices and
  • Chin Straps


By Diagnostic Devices Type

  • Polysomnography
  • Respiratory Polygraphs
  • Pulse Oximeters and
  • Actigraphs


By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Companies Profiled

  • Koninklijke Philips N.V.
  • Fisher & Paykel Healthcare Corporation Limited
  • SomnoMed Limited
  • Mitsui Chemical, Inc. (Whole You, Inc.)
  • Teleflex, Inc.
  • ResMed, Inc.
  • Oventus Medical Ltd.
  • Panthera Dental, Inc. (Panthera Sleep)
  • BRAEBON Medical Corporation
  • BMC Medical Co., Ltd.


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free